Form 4: Xylem Inc. Executive Michael J. McGann Reports Stock and Option Awards
SEC Form 4 Filing
Michael J. McGann, SVP & President of MCS at Xylem Inc., reports the acquisition of restricted stock units and non-qualified stock options.
Summary
- On March 5, 2025, Michael J. McGann, SVP & President, MCS of Xylem Inc., acquired 1,639 shares of common stock at a price of $129.67 per share.
- These shares were awarded as restricted stock units under the Xylem 2011 Omnibus Incentive Plan, vesting in equal installments on March 5, 2026, March 5, 2027, and March 5, 2028.
- On the same date, McGann also acquired 5,751 non-qualified stock options with an exercise price of $129.67, also vesting in one-third increments on March 5, 2026, March 5, 2027, and March 5, 2028.
- Following these transactions, McGann directly owns 8,180 shares of Xylem Inc. common stock and 5,751 non-qualified stock options.
Sentiment
Score: 7
Explanation: The document reflects standard executive compensation practices, which are generally viewed neutrally to positively as they align executive interests with shareholder value. The sentiment is slightly positive due to the incentive structure.
Positives
- The grant of restricted stock units and stock options to a top executive like McGann aligns his interests with those of the shareholders.
- The vesting schedule encourages long-term commitment and performance.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting schedule of the stock options and restricted stock units suggests an expectation of continued service and performance from the executive.
Industry Context
Stock and option awards are a common practice in publicly traded companies to incentivize executives and align their interests with shareholders. The specific terms of these awards, such as vesting schedules and exercise prices, can vary widely based on company performance, industry standards, and individual negotiations.
Comparison to Industry Standards
- Stock option and restricted stock unit grants are standard compensation practices among publicly traded companies, particularly for executive-level employees.
- Companies like Danaher (DHR) and Roper Technologies (ROP), which operate in similar industrial technology sectors, also utilize equity-based compensation to incentivize their leadership teams.
- The vesting schedules, typically three to four years, are in line with industry norms to promote long-term commitment.
- The specific number of shares and option grants are tailored to the individual's role, performance, and the company's overall compensation strategy.
Stakeholder Impact
- The stock and option awards incentivize the executive to improve company performance, which benefits shareholders.
- The awards do not have a direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 02/24/2016 | Date the Xylem 2011 Omnibus Incentive Plan was Amended and Restated |
| 03/05/2025 | Date of transaction: Acquisition of restricted stock units and non-qualified stock options |
| 03/05/2026 | First vesting date for both restricted stock units and non-qualified stock options |
| 03/05/2027 | Second vesting date for both restricted stock units and non-qualified stock options |
| 03/05/2028 | Final vesting date for both restricted stock units and non-qualified stock options |
| 03/05/2035 | Expiration date for the non-qualified stock options |
| 03/06/2025 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.